久久久精品456亚洲影院,国产精品九九,午夜影院福利,尻逼影院
<ul id="8s0wc"></ul>
<strike id="8s0wc"><menu id="8s0wc"></menu></strike>
<cite id="8s0wc"><table id="8s0wc"></table></cite>
Home
About
Capabilities
R&D
Investors
News
Careers
中文
Home
About
Capabilities
R & D
Investors
News
Careers
Press Release
Press Release
2025
2024
2023
2022
2021
2020
2019
2018
2017
Jun 04, 2025
Highlights in Poster Presentations of Mabwell at 2025 ASCO
?
Jun 04, 2025
Highlights in Oral Presentation of Mabwell's 9MW2821 at 2025 ASCO
?
May 29, 2025
Mabwell Receives NMPA Approval for Albipagrastim alfa for Injection (MAILISHENG)
?
May 23, 2025
Mabwell Announces Clinical Data of Multiple ADCs to be presented at 2025 ASCO Annual Meeting
?
Apr 30, 2025
Mabwell Releases 6 Study Results of Innovative Drugs and Platforms at the 2025 AACR Annual Meeting
?
Apr 24, 2025
Mabwell to Present Clinical Data of 9MW2821 Combined with Toripalimab in Patients with UC in an Oral Presentation at 2025 ASCO
?
Apr 14, 2025
Mabwell and DP Technology Announces Strategic Cooperation to Build a New Research Paradigm for R&D of Innovative Drug
?
Apr 02, 2025
Mabwell Announces NMPA Approval to Initiate Clinical Trial of novel B7-H3-targeting ADC for Advanced Solid Tumors in Combination with PD-1 Inhibitor
?
Mar 27, 2025
Mabwell and Insilico Medicine Announce Strategic Collaboration to Empower R&D of ADC with AI
?
Mar 26, 2025
Mabwell to Present results of 6 studies at the 2025 American Association for Cancer Research (AACR) Annual Meeting
?
1
2
Next
